Hernday Natasha 4
4 · ALPINE IMMUNE SCIENCES, INC. · Filed Jan 5, 2023
Insider Transaction Report
Form 4
Hernday Natasha
Director
Transactions
- Award
Stock Option (Right to buy)
2023-01-03+10,000→ 10,000 totalExercise: $7.43Exp: 2033-01-02→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
- [F2]1/12th of the shares subject to the option become vested and exercisable on February 3, 2023 and 1/12 of the shares subject to the option shall vest monthly thereafter.